Deep Track Capital, LP Viridian Therapeutics, Inc.\De Transaction History
Deep Track Capital, LP
- $3.05 Billion
- Q2 2024
A detailed history of Deep Track Capital, LP transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Deep Track Capital, LP holds 3,923,849 shares of VRDN stock, worth $87 Million. This represents 1.68% of its overall portfolio holdings.
Number of Shares
3,923,849
Previous 3,456,053
13.54%
Holding current value
$87 Million
Previous $60.5 Million
15.64%
% of portfolio
1.68%
Previous 2.0%
Shares
10 transactions
Others Institutions Holding VRDN
# of Institutions
151Shares Held
61.9MCall Options Held
133KPut Options Held
207K-
Black Rock Inc. New York, NY4.77MShares$106 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY3.88MShares$86.1 Million5.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.35MShares$74.2 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx3.31MShares$73.3 Million0.85% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.9MShares$64.2 Million1.52% of portfolio
About Viridian Therapeutics, Inc.\DE
- Ticker VRDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,888,900
- Market Cap $884M
- Description
- Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...